Clinical phenotype of a Chinese patient with RIPK1 deficiency due to novel mutation

Li Lin; Ying Wang; Luyao Liu; Wenjing Ying; Wenjie Wang; Bijun Sun; Jinqiao Sun; Xiaochuan Wang

doi:10.1016/j.gendis.2019.10.008

您当前的位置：

首页 >

文章列表页 >

Clinical phenotype of a Chinese patient with RIPK1 deficiency due to novel mutation

Full-length article | 更新时间：2022-06-24

- Clinical phenotype of a Chinese patient with RIPK1 deficiency due to novel mutation
- Clinical phenotype of a Chinese patient with RIPK1 deficiency due to novel mutation
- Genes & Diseases 2020年7卷第1期
- 作者机构：
  
  Department of Clinical Immunology, Children's Hospital of Fudan University,Shanghai,China,201102
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2019.10.008
  中图分类号：
- 纸质出版日期：2020，
  
  网络出版日期：2020-3-1，
扫描看全文
Li Lin, Ying Wang, Luyao Liu, 等. Clinical phenotype of a Chinese patient with RIPK1 deficiency due to novel mutation[J]. Genes & Diseases, 2020,7(1).

Li Lin, Ying Wang, Luyao Liu, et al. Clinical phenotype of a Chinese patient with RIPK1 deficiency due to novel mutation[J]. Genes & Diseases, 2020,7(1).
Li Lin, Ying Wang, Luyao Liu, 等. Clinical phenotype of a Chinese patient with RIPK1 deficiency due to novel mutation[J]. Genes & Diseases, 2020,7(1). DOI： 10.1016/j.gendis.2019.10.008.

Li Lin, Ying Wang, Luyao Liu, et al. Clinical phenotype of a Chinese patient with RIPK1 deficiency due to novel mutation[J]. Genes & Diseases, 2020,7(1). DOI： 10.1016/j.gendis.2019.10.008.

摘要

Abstract

umulating evidence indicates that

RIPK1

is associated with inflammation and apoptotic.

RIPK1

deficiency leads to proinflammatory signaling impaired. However

only few patients with homozygous loss-of-function mutation in

RIPK1

gene had been reported until now. Here

we report a Chinese combined immunodeficiency patient. He had recurrent infection

diarrhea after 3 months old. Immune function indicated that T

B and NK cells decreased significantly but immunoglobulins approximately remained normal. Whole-exome sequencing indicated that he had novel compound heterozygous mutations (c.998 C

A from his mother and c.1934 C

T from his father) in

RIPK1

gene

which were confirmed by Sanger sequencing. Our study reports novel mutations in

RIPK1

gene and new phenotype of patient with

RIPK1

deficiency.

关键词

Keywords

Combined immunodeficiencyInflammatory bowel diseaseMutationRIPK1

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

CRISPR/Cas9 system and its applications in nervous system diseases

Genetic profiles of familial late-onset Alzheimer's disease in China: The Shanghai FLOAD study

Reduced neutralization of SARS-CoV-2 B.1.617 variant by convalescent and vaccinated sera

A novel ABCD1 G1202A mutation in a Chinese patient with pure adrenomyeloneuropathy and literature review

The R168G heterozygous mutation of tropomyosin 3 (TPM3) was identified in three family members and has manifestations ranging from asymptotic to serve scoliosis and respiratory complications